Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
    • Natanael@slrpnk.netEnglish
      42·
      17 days ago

      That’s an exceptionally ironic response to scientific studies pointing mapping out the chemical processes behind the above. You’re just desperately trying to justify feeling better than others.

      Some people can drop severe drug addictions on their own. Most can’t. Do you treat ex addicts that way too? Tell them it’s agency and responsibility when their fucked up chemical response messes with their head?

      If you actually wanted to help others, you’d spend less time condemning people you don’t know and spend more time figuring out why they have problems